RICHLAND BIOTECH PTE. LTD.

Business Description

RICHLAND BIOTECH PTE. LTD. is registered as a business entity on 13 August 2015 (9.5 years ago) structured as a Exempt Private Company Limited By Shares (Local Company) with 3 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 201531720Z. The business official address is located at 160 Paya Lebar Road #07-08, Orion @ Paya Lebar, Singapore 409022 with main trading activity as Biotech Cosmetics Products Research/sale, Nature Plants Products Research/sale in the primary industry of 20233: Manufacture Of Cosmetics And Toiletries using Singapore Dollars - SGD as its default trading currency. The business legal name has undergone change(s) and is previously known as LONGSING BIOTECH PTE. LTD.. The business annual account filing date falls on 31 January and is no longer operational with the status of 'Struck Off'. The business paid up share capital is SGD 200,000, with preference share capital of SGD 0, and other share capital at SGD 0.

In the past 365 days, RICHLAND BIOTECH PTE. LTD. has received a total of Login to view reported payment review(s). 0 were rated Good and Login to view were rated Poor. Therefore no payment reviews were made recently. The aggregated good payment amount is equivalent to USD 0, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "D" suggest a bad payment culture where settlement with stakeholders is frequently past due. Since the business is no longer active, please take caution if you continue transacting as a counter-party. The lack of an appointed auditor indicates that the business is small sized as it did not meet the regulatory requirements of revenue or assets exceeding SGD 10 million, or has more than 50 employees in the previous two fiscal years.

RICHLAND BIOTECH PTE. LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023